Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Diastolic dysfunction as a cause of heart failure
1993
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy
1995
Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients
2004
Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding
1996
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Left ventricular hypertrophy: An initial response to myocardial injury
1992
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
2003
Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog
1993
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
2005
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
2004
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Reduced Coronary Vasodilator Function in Infarcted and Normal Myocardium after Myocardial Infarction
1994
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
2003
Exercise Standards for Testing and Training
2013 Standout
Hypertrophic cardiomyopathy
1997
Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart
2002 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities11Each of the authors contributed significantly to the submitted work including: 1) conception and design of the project and/or interpretation of data; 2) drafting and/or revising the manuscript, and 3) final approval of the submitted manuscript.
1999
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
HEART FAILURE WITH NORMAL SYSTOLIC FUNCTION
2000
Negative Ionotropic Agents for the Treatment of Left Ventricular Outflow Tract Obstruction Due to Sigmoid Septum and Concentric Left Ventricular Hypertrophy
2011
Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy∗∗∗∗A list of participating hospitals, central agencies and personnel appears in reference 26.
2000
Surgical management of hypertrophic obstructive cardiomyopathy
1995
Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
1995
Reflex control of immunity
2009 Standout
Hypertrophic cardiomyopathy
1994
Natural history of hypertrophic cardiomyopathy in the elderly
1990
Yield of Genetic Testing in Hypertrophic Cardiomyopathy
2005
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
2015 Standout
Clinical course of hypertrophiccardiomyopathy with survival to advanced age
2003
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy
2009
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure
1996
Stem cells, ageing and the quest for immortality
2006 StandoutNature
Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥ 65 years of age
1994
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
The diagnosis of hypertrophic cardiomyopathy
2001
Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy
2004
Nonparallel changes in global left ventricular chamber volume and muscle mass during the first year after transmural myocardial infarction in humans
1993
HYPERTROPHIC AND RESTRICTIVE CARDIOMYOPATHIES THE ELDERLY
1999
The role of vagal function in the risk for cardiovascular disease and mortality
2006 Standout
Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction
1994
Hypertrophic Cardiomyopathy
2002 Standout
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction*
2010
Outflow Acceleration Assessed by Continuous-Wave Doppler Echocardiography in Left Ventricular Hypertrophy: An Analysis of 103 Consecutive Cases
1998
Long-Term Effects of Dual-Chamber Pacing With Periodic Echocardiographic Evaluation of Optimal Atrioventricular Delay in Patients With Hypertrophic Cardiomyopathy >50 Years of Age
2006
Echocardiography-Guided Genetic Testing in Hypertrophic Cardiomyopathy: Septal Morphological Features Predict the Presence of Myofilament Mutations
2006
The Management of Hypertrophic Cardiomyopathy
1997
Acute cocaine administation: effects on local cerebral blood flow and metabolic demand in the rat
1991
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues
2003
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
2001 Standout
Ventricular remodeling after myocardial infarction. Experimental and clinical studies
1993
Gender differences in arrhythmias
2002
The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors
2009 Standout
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Hypertrophic Cardiomyopathy
1995
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Myocardial Regeneration and Stem Cell Repair
2008
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond
1998
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction
2013
Assignment of patients into the classification of cardiomyopathies.
1992
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
2008 Standout
Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans
2002 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Sudden Cardiac Death
1998 Standout
Yield of Genetic Testing in Hypertrophic Cardiomyopathy
2005
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
1995
Natural History of Hypertrophic Cardiomyopathy
1995
Time-Related Normalization of Maximal Coronary Flow in Isolated Perfused Hearts of Rats With Myocardial Infarction
1996
Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly
2002
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Clinical Approach to Genetic Cardiomyopathy in Children
1996
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
2014
TIMI Frame Count
1996 Standout
Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular disease in the young, and basic science, american heart association
1998
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011
Works of Roger Karam being referenced
The Azimilide Post-Infarct Survival Evaluation (ALIVE) Trial
1998
Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension?: A study of 78 patients
1989
Azimilide Dihydrochloride, a Novel Antiarrhythmic Agent
1998
Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy.
1990
Cocaine-induced small vessel spasm in isolated rat hearts.
1989
Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape.
1989
Mortality in Patients After a Recent Myocardial Infarction
2004